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Summary 
B7-2 is a recently discovered, second ligand for the CTLA-4/CD28,  T  cell signaling  system. 
Using the GL-1 rat monoclonal antibody (mAb), we monitored expression of B7-2 on mouse 
leukocytes with an emphasis on dendritic cells. By cytofluorography, little or no B7-2 was de- 
tected on most cell types isolated from spleen, thymus, peritoneal cavity, skin, marrow, and blood. 
However, expression of B7-2 could be upregulated in culture. In the case of epidermal and spleen 
dendritic cells,  which become highly immunostimulatory  for T  cells during a short period of 
culture, the upregulation of B7-2 was dramatic and did not require added stimuli. Lipopolysac- 
charide did not upregulate B7-2 levels on dendritic cells, in contrast to macrophages and B cells. 
By indirect immunolabeling,  the level of staining with GL-1 mAb exceeded that seen with rat 
mAbs to several other surface molecules including intercellular adhesion molecule 1, B7-1, CD44, 
and CD45, as well as new hamster mAbs to CD40, CD48, and B7-1/CD80. Of these accessory 
molecules, B7-2 was a major species that increased in culture,  implying a key role for B7-2 in 
the functional  maturation  of dendritic  cells.  B7-2 was the main  (>90%)  CTLA-4 ligand  on 
mouse dendritic  cells.  When we applied GL-1  to tissue sections of a dozen different organs, 
clear-cut staining with B7-2 antigen was found in many. B7-2 staining was noted on liver Kupffer 
cells,  interstitial  cells of heart and lung, and profiles in the submucosa of the esophagus. B7-2 
staining was minimal in the kidney and in the nonlymphoid regions of the gut,  and was not 
observed at all in the brain.  In the tongue, only rare dendritic cells in the oral epithelium were 
B7-2 + , but reactive cells were scattered about the interstitial  spaces of the muscle.  In all lym- 
phoid tissues, GI-1  strongly stained certain distinct regions that are occupied by dendritic cells 
and by macrophages.  For dendritic cells, these include the thvmic medulla,  splenic periarterial 
sheaths,  and lymph node deep cortex; for macrophages, the B7-2-rich regions included the splenic 
marginal zone and lymph node subcapsular cortex. Splenic B7-2 + cells were accessible to labeling 
with GL-1 mAb given intravenously.  Dendritic cell stimulation of T cells (DNA synthesis) during 
the mixed leukocyte reaction was significantly  (35-65%)  blocked by GL-1.  The block could 
be enhanced by adding  1G10  anti-B7-1  or by using CTLA-4 Ig,  a ligand  for both B7-1  and 
B7-2.  We conclude that  B7-2, like other accessory molecules, is expressed by many types of 
antigen-presenting  cells. However, the regulation and extent of B7-2 expression seems to differ 
among cell types. Dendritic cells express very high levels, in several sites in vivo and after matura- 
tion into  strong  accessory cells in culture. 
C 
D28 and CTLA-4  are closely related molecules (1, 2) 
that  are  expressed  on  most  T  cells.  CD28  was first 
identified using monoclonals that were comparably mitogenic 
to anti-TCR mAbs, when administered together with PMA 
(3-5). The simultaneous triggering  of CD28/CTLA-4 and 
CD3/TCR,  without PMA, is sufficient to stimulate strong 
T  cell  proliferative  responses  (6-13).  The  costimulation 
provided via CD28CTLA-4 operates at the level of height- 
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15) or mRNA  stability (16). 
Initially, the B7/BB1 molecule was identified as the ligand 
for CD28 and CTLA-4. It is now evident that there are at 
least two ligands, the original B7-1 or CD80 (2,  10, 17-21) 
and the newly recognized B7-2 (22-26).  These molecules, 
when expressed by antigen-presenting B cells or by transfec- 
tion into cell lines, markedly enhance the capacity of the APC 
to induce the production of IL-2 from T  cells. 
Early on it was realized that strong T  cell growth factor 
production was especially characteristic of responses that could 
be elicited by antigen-presenting, dendritic cells (27, 28). Den- 
dritic cells were found to be reactive with reagents that bind 
to BB1 and B7-1 (29-31, and Pope, M., M. Betjes, H. Hir- 
mand, L. Hoffman, and R. M. Steinman, manuscript sub- 
mitted for publication), and accessory function was reduced 
either by soluble CTLA-4 Ig fusion protein (6) or by anti- 
CD28 mAb (29). The possibility of B7-2 expression must 
now be evaluated on dendritic cells  and on other primary 
populations. 
Here we describe indirect immunolabeling evidence that 
B7-2 is abundant on dendritic cells, apparently more abundant 
than most other known surface molecules such as B7-1/CD80, 
intercellular adhesion molecule 1 (ICAM-1)t/CD54, LFA-3 
equivalent/CD48,  CD40,  and CD44.  No other leukocyte 
in culture expresses such high levels of B7-2 as the fully ma- 
ture dendritic cell, whereas B7-1 is much less abundant. Im- 
munocytochemical  studies  for  B7-2  expression  in  many 
different organs indicate that this costimulator is expressed 
at high levels on many populations of macrophages and den- 
dritic cells  in situ. 
Materials and Methods 
Mice.  BALB/c,  (BALB/C  x  DBA/2) F1, C3H (HeSlc, HeJ, 
and HeN) 8-wk-old female mice were purchased from Japan SLC 
(Hamamatsu, Shizuoka, Japan). (BALB/C  x  DBA/2)F1 (Taconic 
Farms Inc., Germantown,  NY), (BALB/C  x  C57BL/6)F1 (The 
Jackson  Laboratory,  Bar  Harbor,  ME),  and  (C57BL/6  x 
DBA/2)F1 (Trudeau Institute,  Saranac Lake, NY) mice were also 
used, 
Cell Suspensions.  Cell suspensions from spleen, thymus, lymph 
node, blood, marrow, skin, and peritoneal cavity were studied im- 
mediately upon isolation or after a period of culture. The medium 
was RPMI-1640 supplemented with 5% FCS, 50/~M 2-ME, and 
20/zg/ml gentamicin. In some cases, LPS was added as a stimulus 
to upregulate expression of  B7 and other accessory  molecules. Peri- 
toneal, spleen (32), and epidermal (33) suspensions were cultured 
in bulk, and then the component B cells, macrophages, and den- 
dritic cells were identified with select mAbs as indicated below and 
in Results. Dendritic  cells also were derived from bone marrow 
progenitors  by culture in rGM-CSF  as described (34). 
Cytofluorography.  A panel ofmAbs was selected to identify sev- 
eral molecular species that contribute to APC function, especially 
the APC-T cell interaction. The rat anti-mouse mAbs were directed 
to anti-B7-2 (GL-1 [22]); ICAM-1/CD54 (YN1/1.7.4;  American 
Type Culture Collection [ATCC], Rockville, MD, #CRL1878); heat 
i Abbreviation used in thispaper: ICAM-1, intercellular  adhesion molecule  1. 
stable antigen (HSA) (M1/69.16.11, ATCC TIB125); MHC class 
II (B21-2, ATCC TIB229, and M5/114, ATCC TIB120); B7-1 (1G10 
[35]); pgp-1/CD44 (2D2C [36]); CD45 (M1/9.3.4; ATCC TIB122); 
NLDC-145 (anti-dendritic cell [37]); B220 (R.A3-6B2 [38]); mac- 
rophage sialoadhesin (SER-4 [39]); and 110-10, a nonreactive IgG2a 
isotype control All the rat mAbs except the anti-class II reagents 
are IgG2as. The hamster anti-mouse mAbs were directed to MHC 
class II (N22, ATCC HB225); CD48 (HM48-1 [40]) CD40 (HM40- 
3,  to be described elsewhere by Yagita, H. et al., raised by im- 
munizing Armenian hamsters with WEHI 231 cells and screening 
for reactivity  with  CHO  cells transfected with  mouse  CD40 
cDNA);  B7-1/CDS0  (16-10A1 [21] and HMB7,  to be described 
elsewhere by Azuma, M. et al. and raised by immunizing Arme- 
nian hamsters with P815 cells transfected with mouse B7 cDNA). 
Biotin-modified mouse anti-Ia  a (mouse IgG2b) was from Phar- 
Mingen (San Diego, CA), and control rat IgG2a and hamster Ig 
were from Jackson ImmunoResearch  Laboratories  (West Grove,  PA). 
Primary mAbs were applied at saturating  levels either as hy- 
bridoma supernatants or as pure Igs (1/zg/ml GL-1 and 1G10) to 
cells for 30 min in PBS-1%, FCS-0.02% azide on ice, washed, stained 
with FITC-mouse anti-rat Ig (FITC-MAR; Boehringer Mannheim 
Biochemicals, Indianapolis, IN) for 30 min on ice. Normal rat Ig 
was added at 500/~g/ml to quench, and then populations were 
stained with a second  mAb to identify specific  cell types. The second 
mAbs were either biotin anti-B220 (B cells [38]; Pharmigen), bi- 
otin anti-MHC class II (Pharmingen), biotin N418 anti-CDllc (den- 
dritic cells [41, 42]; Endogen, Inc., Boston, MA), PE-anti TCR- 
ct/B or PE-antiRB6-SC5 (T cells and granulocytes; Pharmingen). 
PE-streptavidin was from Tago, Inc. (Burlingame, CA). For staining 
with CTLA-4 human Ig fusion protein, 10 #g/ml followed  by FITC 
anti-human Ig was used, with CD7 human Ig or polyclonal  human 
IgG1 as controls. 
T Cell Stimulation.  T cells  were purified from mixtures of spleen 
and lymph node by passage over nylon wool plus treatment with 
anti-MHC class II, anti-B220, and J11d monoclonals plus rabbit 
complement. T cells were added at a dose of 3  x  10  s (allogeneic 
MLR, syngeneic MLR,  and Mls responses) or 2  x  105 (stimula- 
tion with 2Cll hamster anti-mouse CD3 hybridoma supematant 
at 5% vol/vol) in flat-bottomed microtest wells (Nunc, Naperville 
IL; Corning,  Coming, NY). The stimulator cells were either ad- 
herent spleen cells or LPS-stimulated B cells that  had been cul- 
tured overnight before use and were treated with mitomycin-C (40 
/zg/ml  for  30  min  at  37~  To  measure DNA  synthesis, 
[3H]thymidine was  added at  4  /~Ci/ml  or  148  KBq/ml  (222 
GBq/mmol, American Radiolabeled Chemicals, Inc., St. Louis, 
MO;  183 GBq/mmol, New England Nuclear, Boston, MA) at 
36-48 h (anti-CD3) and 84-96 h (MLR. and Mls). To measure IL-2 
release, aliquots of culture supernatant were assayed  by ELISA (En- 
dogen,  Inc.). 
Immunocytochemistry.  Organs were removed and immediately 
frozen in OCT medium. Cryostat sections were cut at 10/zm and 
applied to 10-well multiwell  slides (Carlson Scientific Inc., Peo- 
tone, IL). The sections could be stored at  -20~  or stained im- 
mediately. The slides were fixed in absolute acetone for 10 min, 
rinsed in PBS, and stained with mAbs followed by peroxidase- 
conjugated F(ab')2 donkey anti-rat Ig (Jackson ImmunoResearch 
Laboratories). Diaminobenzidine  was the chromogen. In some cases, 
the sections were counterstained with Gill's hematoxylin (Fisher 
Scientific, Fair Lawn, NJ). Several  experiments were first performed 
using lymphoid tissues (spleen and thymus primarily), and then 
a systematic tour of 12 different organs (see Results) was done in 
two mice. 
1850  Tissue  Distribution of the B7-2 Costimulator in Mice Cells 
Fresh  Spleen 
Low-density  B cell 
DC 
Spleen low-density 
adherent,  cultured 
B cell 
DC 
Spleen low-density 
non-adherent,  cultured  B cell 
[]  rlgG2a 
￿9  B21-2 
[]  B7-2 
[]  ICAM-1 
￿9  LFA-1 
[]  CD44  " 
I  ~oc 
,  !  ! 
~x\\\x~\\\\\\x~\x\\\\\xxxx  ~x~xx\x\~x\~x\\\\x\~ 
i  i 
~,,,i  ....  i ........  , ....  i ......... 
0  1  O0  200  300  400  500  600  700 
Mean Fluorescence  Intensity 
Figure  1.  B7-2 antigen is upregulated  on cul- 
tured B cells and dendritic cells. A fraction of spleen 
with a low buoyant density, which is enriched in 
dendritic cells and activated B cells (32, 42), was 
stained with  a panel  of rat anti-mouse  mAbs  as 
indicated and analyzed on a FACS  |  The cells were 
stained either fresh or after overnight culture. Den- 
dritic cells were identified with  an N418  double 
label and were the major cell type in the plastic 
adherent  fraction.  B  cells were identified with  a 
B220  double label and were present  in both  ad- 
herent and  nonadherent  fractions. 
Results 
B7-2 Expression  on Isolated Leuteocytes: Cytofluorography.  To 
gain information on the tissue distribution of the new B7-2 
costimulator, especially on immunostimulatory dendritic cells, 
we utilized the mAb GL-1 that has been raised to this mole- 
cule (22). Spleen was studied first since this organ is the most 
frequently used for analyzing the immune functions of mouse 
leukocytes, including dendritic cells.  To enrich for the trace 
subset of dendritic cells, a fraction with a low buoyant den- 
sity (5-10%  of spleen) was prepared  (32,  42) and analyzed 
immediately using anti-B220 and anti-CDllc (41-43) mono- 
clonals to selectively label B and dendritic cells, respectively. 
Both B  and dendritic cells expressed MHC class  II, as well 
as  several  adhesion  molecules  including  ICAM-1/CD54, 
LFA-1/CDlla,  and pgp-1/CD44;  however, only trace levels 
of the B7-2  costimulator were  detected  (Fig.  1,  top). 
The  spleen cells  were  then  separated  into  adherent  and 
nonadherent fractions,  the former containing most of the den- 
dritic cells but some B cells as well, and cultured overnight. 
For each of the cultured populations,  there was  some up- 
regulation in the levels of MHC class II, ICAM-1, LFA-1, 
and CD44.  However,  the increase  in B7-2 was particularly 
dramatic on dendritic cells (Fig. 1, middle) where the staining 
was greater than that seen with anti-MHC class II. Whereas 
GL-1 was an IgG2a mAb, and the anti-class II an IgG2b mAb, 
the secondary FITC-mouse anti-rat  Ig reacted  better with 
IgG2b than IgG2a primary mAbs as assessed with anti-CD44 
mAbs of the two isotypes (data not shown). B7-1 also was 
upregulated during culture, but the level of staining with 
the isotype-matched 1G10 mAb was <10% of than that seen 
with GL-1 anti-B7-2 (data not shown in Fig. 1, but see Fig. 4). 
Expression of B7-2 in spleen cells was compared with that 
of ceils from several other organs. Peritoneal B cells and mac- 
rophages expressed very low levels of B7-2,  but substantial 
levels of CD54 and CD44 (Fig. 2, PECs).  Fresh spleen and 
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Figure  2.  B7-2 antigen  expres- 
sion is abundant on dendritic calls. 
Cell suspensions were prepared from 
a variety of different  sites as indi- 
cated on the x-axis. PECs are freshly 
isolated peritoneal cells in which B 
cells and macrophages were distin- 
guished by light scattering.  Spleen 
and lymph node cells were stained 
fresh or after culture  as in Fig.  1. 
B  cells  were  double  stained  with 
B220 mAb,  and T  cells with anti- 
TCR  mAb.  Neutrophils  (PMNs) 
were identified with an R.B6 mAb 
in  fresh  bone  marrow.  Dendritic 
cells were studied from three tissues: 
GM-CSF-stimulated  marrow  cul- 
tures as described (34), fresh and cul- 
tured spleen low density cells as in 
Fig. 1, and epidermal dendritic cells 
identified by double labels with anti- 
MHC class II in skin cultures main- 
tained for 0,  1,  2,  or 3  d  (33). 
1851  Inaba et al. Table  1.  LPS Upregutates B7-2 on Macrophages and B 
Lymphocytes, but not Dendritic Cells 
Cell type 
Level of B7-2 
Mouse strain  LPS  Expt.  1  Expt.  2 
Epidermal  C3H/HeN  -  483  510 
dendritic  +  ND  510 
cells  C3H/HeJ  -  481  487 
+  ND  486 
Peritoneal  C3H/HeN  -  136  69 
macrophages  +  205  121 
C3H/HeJ  -  132  49 
+  80  48 
Peritoneal  C3H/HeN  -  101  63 
B cells  +  211  163 
C3H/HeJ  -  87  21 
+  101  27 
Three different  cell types  from  LPS responsive (C3H/HeN) and nonrespon- 
five (C3H/HeJ) strains were cultured 24 h +- LPS and then analyzed 
for B7-2 expression on the FACS  |  The mean fluoresxence  of B7-2 on 
fresh epidermal  isolates was <40 as in Fig. 2. Data are mean fluorescence 
intensity minus background staining with nonreactive IgG2a antibody 
(background was about 4 for dendritic  cells and B cells, and 40 for mac- 
rophages). In experiment 1, LPS was at 30 #g/ml whereas in experi- 
ment 2, LPS was at 1 #g/ml. In experiment 1, LPS was accidentally 
omitted from the dendritic  cell cultures (ND), but there was no increase 
in B7-2 in companion  cultures with CxD2 F1 epidermal  dendritic  cells. 
lymph node B cells expressed little or no surface B7-2,  but 
the low density subpopulation of B cells could upregulate 
B7-2 upon culture (Fig. 2, B cell adherent and nonadherent 
part of histogram). Splenic and lymph node T cells, and bone 
marrow neutrophils, had little or no B7-2 (Fig. 2). Dendritic 
cells from several different sites could express high levels of 
B7-2, but only upon culture (Fig. 2). This was true of den- 
dritic cells from spleen, skin (epidermal Langerhans cells [LCs] 
and bone marrow after 7-d growth of precursors  using GM- 
CSF as described (34). 
We were concerned that sufficient  LPS might have been 
present in the cultures to upregulate B7-2 expression.  Hath- 
cock et al. (44) have shown that LPS upregulates B7-2 ex- 
pression, and we confirmed this with peritoneal B cells and 
macrophages (underlined, Table 1). We chose to study the 
LPS-responder and nonresponder strains, C3H/HeN and HeJ, 
for B7-2 expression before and after culture. B7-2 was markedly 
upregulated (increase in mean fluorescence from <40 to >400) 
when either C3H/HeN or C3H/HeJ dendritic cells from 
spleen and skin were cultured overnight (Table 1). The FACS  | 
(Becton Dickinson & Co., Mountain View, CA) signal for 
B7-2 on cultured epidermal dendritic cells was 100  x  back- 
ground, and for macrophages, 2-5  x  background (Table 1). 
In additional experiments, we looked for expression orB7-2 
on fresh isolates  of leukocytes from blood,  marrow,  and 
thymus. Little or no B7-2 staining over the background IgG2a 
isotype control was observed, except for a weak level of stain 
on the N418 § subset of thymic dendritic cells (43) (which 
could increase markedly in culture, data not shown). We con- 
clude that B7-2 is expressed  at very low levels on standard 
suspensions of freshly isolated mouse leukocytes, but that the 
costimulator can be upregulated in culture, particularly on 
dendritic cells. 
Comparison of Dendritic Cell B7-2 Expression with other Sur- 
face Molecules, including B7-1.  The increase of GL-1 staining 
on  cultured  dendritic  cells  was  monitored in  spleen  and 
epidermal dendritic cells, as in Fig. 2, however, GL-1 staining 
was compared to a large panel of other mAbs, including re- 
cently isolated hamster mAbs to mouse CD40, CD48, and 
CD80/B7-1 (see Materials and Methods). The epitopes rec- 
ognized by these mAbs, like all of the epitopes  seen by the 
rat mAbs except for 2D2C anti-CD44 and NLDC-145, were 
affected minimally by the level of trypsin that was used to 
prepare  the epidermal dendritic cells (data not shown). For 
the rat mAbs, B7-2 was the accessory molecule that was most 
strikingly upregulated during overnight culture (Fig. 3). CD54 
or ICAM-1 also increased  substantially.  HSA, CD44,  and 
CD45 were upregulated minimally, if at all (CD44 is trypsin 
sensitive). 
For the hamster mAbs (Fig.  3, bottom), CD40 and B7-1 
(mAbs HM40-3 and HMB7) increased  in culture, but the 
absolute levels were relatively low. CD48, the ligand for mouse 
CD2 detected with mAb HM48-1 (40), was not upregulated 
on cultured dendritic cells. To compare the extent of staining 
with hamster vs rat mAbs, one can use the data with the 
hamster and rat anti-MHC class II reagents. 
Expression of B7 molecules frequently is assessed using 
a fusion protein generated by a construct in which the ex- 
ternal domains of CTLA-4 have been fused to the Ig-C do- 
mains of human Ig~ (2).  CTLA-4 Ig binds to B7-2  and to 
B7-1. CTLA-4 binding was markedly upregulated in culture 
(Fig. 3, bottom left), confirming the prior work of Larsen et 
al. (6). The binding of CTLA-4 Ig closely paralleled binding 
of the B7-2  mAb, GL-1. 
To further assess the relative expression orB7-1 and B7-2, 
we compared staining by FACS  |  analyses using the 1G10 and 
GL-1 isotype-matched mAbs. GL-1 anti-B7-2  staining was 
at least 10 times greater than 1G10 anti-B7-1 staining on both 
splenic and epidermal dendritic cells (Fig. 4, left). We then 
did blocking studies to show that CTLA-4 Ig at 1/~g/ml 
totally blocked the binding of B7-2 mAb to dendritic cells, 
and B7-2  mAb blocked CTLA-4 binding >90%  (Fig.  4, 
right). 
We conclude that dendritic cells express several adhesion 
and costimulatory  molecules, but B7-2 appears to be the most 
abundant and most dependent upon culture for its upregula- 
tion. Given the fact that the immunostimulatory properties 
of dendritic cells rise markedly in culture (33,  45, 46),  the 
results suggest that B7 expression is a critical element of matu- 
ration. These findings also emphasized a need to assess the 
expression  of B7-2  and B7-1  on cells in situ. 
Expression of B7-2 in Tissue Sections of Several Nonlymphoid 
Organs.  The binding of B7-2 to cryostat sections was visual- 
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Figure  3.  B7-2 on dendritic cells is abundant relative to other cell surface molecules.  Spleen or epidermal dendritic cells were stained with a panel 
of mAbs,  fresh  (day 0),  or after  1-3  d  in culture.  The  mAbs  (see Materials  and Methods)  were of rat,  hamster,  or human  (CTLA4-Ig)  origin. 
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Figure  4.  Relative  expression  of 
the CTLA-4  ligands B7-1 and B7-2 
on dendritic cells. (Left)  2-d cultures 
of splenic and epidermal dendritic 
cells were stained with a nonreac- 
tive antigranulocyte  antibody  (Gr), 
or with 1G10 anti-B7-1 and GL-1 
anti-BT-2 mAbs. (Right) Cultures 
of epidermal dendritic cells were 
stained with GL-1 anti-B7-2 in the 
presence of graded doses of blocking 
CTLA-4 Ig  (top) or  vice versa 
(bottom) to show that B7-2 is the 
major CTLA-41g  binding species  on 
dendritic cells. 
ized with  a  peroxidase  F(ab')2  donkey anti-rat  Ig.  Other 
mAbs (see Materials and Methods) were applied to adjacent 
sections to localize B cells,  T  cells,  macrophages,  and den- 
dritic cells. Shown here are data comparing staining with GL-1 
anti-B7-2 with antimacrophage and anti-MHC class II mAbs. 
The  1G10  and 16-10A1  anti-B7-1  mAbs did not stain any 
of the tissues we studied, even though strong staining was 
observed on COS cells transfected with B7-1 cDNA and fixed 
similarly  to the tissue sections (data not  shown). 
In  liver,  GL-1  staining  paralleled  that  seen  with  an- 
timacrophage and anti-MHC class II mAbs; however, GL-1 
staining was weaker (Fig.  5, top).  The B7-2 was expressed 
by sinusoidal lining profiles, presumably Kupffer cells,  the 
mononuclear  phagocytes of the liver. 
In the heart, GL-1 staining again paralleled that seen with 
antimacrophage  and anti-MHC  class  II antibodies (Fig.  5, 
middle). As in liver,  the GL-1 staining was not as strong as 
the staining with mAbs to macrophages and MHC class II. 
For each mAb, the reactive cells were found in the interstitial 
spaces throughout  the cardiac muscle. We did not perform 
double labeling studies, but prior work by Spencer and Fabre 
(47) has shown that in the rat, separate macrophage (MHC 
class II weak) and dendritic cell (MHC class II strong) popu- 
lations  occupy the interstitium  of rat  heart. 
In the tongue (Fig.  5, bottom),  anti-MHC class II stained 
the dendritic cells found in a suprabasal position within the 
stratified squamous epithelium (particularly the dorsal aspect 
of the tongue shown here).  Class II § cells also were found 
beneath the epithelium and scattered throughout  the inter- 
stitial spaces of the tongue muscle.  SER-4 antimacrophage 
did not stain the stratified  squamous epithelium, but did stain 
numerous profiles just below the epithelium (Fig. 5, bottom 
le~) and throughout the interstitial  spaces of the tongue muscle 
(data not shown). GL-1 stained a few epithelial dendritic cells 
strongly (Fig. 5, bottom), and weakly stained profiles beneath 
the epithelium and throughout the muscle, in a distribution 
similar to that of the antimacrophage mAb. The findings with 
esophagus (data not shown) were similar to those with tongue. 
For example, anti-MHC class II stained dendritic cells in the 
stratified  squamous  epithelium,  whereas  GL-1  anti-B7-2 
stained but a few, and SER-4 antimacrophage none. In con- 
strast, submucosal profiles stained strongly with antimacro- 
phage and less strongly with anti-B7-2. Therefore, most den- 
dritic cells in the stratified squamous epithelium have little 
B7-2, as is the case in epidermal cell suspensions (Figs. 2 and 3). 
In several other organs (data not shown), the profiles that 
stained with GL-1 anti-B7-2 were found in the same regions 
as SER-4 + macrophages,  but the number and intensity of 
B7-2 profiles were much less. B7-2 + profiles were noted in 
the interstitium of the lung, particularly around vessels and 
bronchi, in small numbers in the interstitium of the kidney 
and  salivary glands,  and at  the base of the lamina  propria 
and  submucosa of the  small intestine.  None of the mAbs 
(SER-4, GL-1, and M5/114) stained profiles in the brain pa- 
renchyma,  where microglia are abundant. 
Expression  of B7-2 in  Tissue Sections of Lymphoid Organs. 
More abundant staining with GL-1 was noted in lymphoid 
relative to nonlymphoid organs, even though suspensions  iso- 
lated from these organs expressed so little antigen by FACS  | 
analyses (Fig.  2). Therefore, we suspect that the bulk of the 
1854  Tissue  Distribution of the B7-2 Costimulator in Mice Figure  5.  Distribution of B7-2 antigen in nonlymphoid tissues. Sections from nonlymphoid organs (liver, heart, and tongue) were stained with the 
GL-1 anti-B7-2 mAb (c, f, and i). Adjacent sections were stained with mAbs that help localize B and T cells, macrophages, and dendritic cells. Shown 
here on the left is anti-macrophage mAb (FA-11 anti-CD6g [56] for liver or SER-4 antisialoadhesin [39] for heart and tongue) and in the middle, 
M5/114 anti MHC class II. In the liver, sinusoidal lining macrophages (arrows) are stained with all three mAbs. In heart, interstitial cells (arrows) are 
stained throughout the myocardium. In tongue, SER-4 positive macrophages  lie beneath the oral epithelium (arrows), whereas MHC class II positive 
dendritic cells are found in a suprabasal location within the epithelium (arrows). GL-1 stains occasional  epithelial dendritic cells as shown here (arrows), 
and also stains subepithelial profiles weakly. 
staining  to be described  in lymphoid tissues  is present  on 
stromal elements that are difficult to release into suspension 
(see Discussion). These B7-2 strong elements were in most 
cases confined to regions known to be rich in either macro- 
phages or dendritic cells, as verified by staining adjacent see- 
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tions with appropriate mAbs, e.g., SER-4, FA-11, and F4/80 
for macrophages, and NLDC-145 and N418 for dendritic cells 
(for  an example  see  reference 42). 
In lymph node, GL-1 staining was strong in the subcap- 
sular  sinus,  a  region  that  is  rich in  SER-4 +  macrophages Figure 6.  (Tbp)  Distribution of B7-2 antigen in lymph node. Sections  from lymph node are shown to contrast the distribution of stain with SER-4 
antimacrophage, M5/114 MHC class II, and GI:I anti-B7-2. Not shown is the lack of staining with 1G10  anti-B7-1. In lymph node, the B cell follicles 
and T cell areas are marked, whereas an arrowhead points to the macrophage-rich, subcapsular region. 
Figure 7.  (Bottom)  Distribution of MHC class II and B7-2 antigens in regions of lymphoid organs that are known to be enriched in dendritic cells. 
(a-c) MHC class II stains; (d-J) B7-2 stains. In lymph node (a and d), the T cell area contains the postcapillary venules and many irregular profiles 
that stain strongly for MHC class II and B7-2. In spleen (b and e), the T cell area surrounds the central artery (arrow), and stains similarly to lymph 
node. In thymus (c and j), MHC class II and B7-2 profiles are in the medulla (M). The cortex (C) contains abundant epithelium that stains for class 
II but not B7-2. B7-2 weakly stains scattered cortical profiles (arrow), and these profiles have the same distribution as macrophages. 
(compare Fig. 6, a and c, arrowheads).  It is interesting to note 
that this macrophage-rich region could express relatively little 
MHC class II (Fig. 6/~ arrowhead). The B cell follicles stained 
with anti-MHC  class II, but only weakly for the B7-2 an- 
tigen.  Dendritic cells are known  to be concentrated in the 
T  cell-rich, deep cortical areas (37, 48-50). These areas con- 
tained many dendritic profiles that were rich in both MHC 
class II and B7-2, but that lacked macrophage sialoadhesin 
(Fig.  6,  Fig.  7,  a  and  d). 
In spleen, GL-1 again stained certain macrophages strongly, 
particularly the marginal metaUophils that surround the white 
pulp nodule and are identified with SER-4 in adjacent  sec- 
tions (data not shown).  Both MHC  class II and B7-2 were 
expressed strongly on dendritic profiles in the T  cell regions 
that  occupy the center of the white pulp  (Fig.  7,  b and e). 
These periarterial regions are a known depot of dendritic cells 
(37, 42, 49-51). Staining of the B cell follicles for B7-2 was 
weak, with the exception of scattered profiles, possibly mac- 
rophages  (data  not  shown). 
In Peyer's patch (data not shown), GL-1 showed staining 
beneath the dome of the epithelium, on scattered profiles in 
the B cell follicles, and on many dendritic profiles in the in- 
terfollicular T  cell areas. 
In thymus, a network of abundant B7-2 and MHC class 
II antigen was evident in the medulla,  the known location 
for most  thymic dendritic cells  (50,  52-54)  (Fig.  7,  c and 
f). B7-2 weak profiles were scattered throughout the cortex 
(arrow, Fig. 7f), in a pattern similar to that exhibited by cor- 
tical macrophages.  MHC  class II was  abundant  on thymic 
cortical epithelium, where B7-2 could not be detected (Fig. 
7,  c and f). 
Since isolated leukocytes stained so weakly with GL-1, we 
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Figure  8.  Blocking  effects  of 
GL-1 mAb on T  cell proliferative 
responses to dendritic cells or LPS- 
induced  B  blasts.  C57BL/6  x 
DBA/2  F1 (H-2 bxd) APCs were 
irradiated and used to stimulate syn- 
geneic T  cells (syn MLR), MHC- 
disparate  BALB/c  x  DBA/2  F1 
(H-2  dxd)  T  cells  (AIIo-MLR), 
Mls-1 disparate BALB/c x  C57BL/6 
T  cells (Mls), or syngeneic T  cells 
in the presence of 2Cll  anti-CD3 
mAb. Shown here are data with two 
doses  of APCs  in  the absence of 
blocking mAb or in the presence of 
control rat IgG2a, Gbl anti-B7-2, 
1G10  anti-B7-1,  CTLA-4  Ig,  and 
CD7  lg,  each at  1  #g/m1.  DNA 
synthesis was used as the measure 
of the T  cell response. 
considered the possibility that the GL-1  staining in tissue 
sections reflected intracelhilar biosynthetic pools rather than 
cell surface antigen. To prove that GL-1 was in fact expressed 
on the surface of macrophages and dendritic cells in situ, we 
injected 50/xg of GL-1 Ig intravenously and 50/~g of a non- 
reactive IgG2a mAb.  16 h later,  the spleens were removed 
for sectioning and staining with anti-Ig.  No staining was 
seen if control IgG2a had been injected, but after GL-1 injec- 
tion, the antibody was distributed in a pattern identical to 
that seen with direct application of GL-1 to sections, and 
nearly as strong (data not shown). Therefore, the B7-2 an- 
tigen is very likely to be expressed at the cell surface to be 
able to selectively trap the corresponding monoclonal, GL-1. 
Blocking Dendritic Cell Function at the Level of the B7 Costimu- 
lator System.  T cell responses to B7-2-bearing APCs were 
monitored with three different types ofligands for the TCR 
(allogeneic and syngeneic MHC,  the Mls-1 ~ superantigen, 
and anti-CD3). GL-1 anti-B7-2 significantly reduced stimu- 
lation by both dendritic cells and B blasts over a broad range 
of APC doses (Fig.  8). The block of dendritic cell function 
in four experiments ranged from 35 to 65% and was com- 
parable using doses of 1 to 5 #g/ml. 1G10 anti-B7-1 exerted 
a weak blocking effect and this was additive when 1G10 and 
GL-1 were tested together. Likewise, CTLA-4  Ig blocked 
T cell stimulation better than anti-B7-2, and CTLA-4 would 
be expected to block both B7-1 and B7-2 costimulators (Fig. 8). 
When IL-2 production was measured (data not shown), 
we again observed a much better block with GL-1 anti-B7-2 
(~70%)  than  1G10 anti-B7-1  (~20%),  and that CTLA-4 
Ig blocked better than GL-1. We conclude that B7-2 is the 
most prevalent CTLA-4/CD28 ligand on dendritic cells and 
accounts for the costimulation provided by this pathway during 
several in vitro immune responses. 
Discussion 
Prior work has shown that dendritic cells in certain sites 
are immunologically immature, i.e.,  the cells do not act as 
potent APCs for several T cell responses. Functional immatu- 
rity is evident in dendritic cells isolated from mouse spleen 
(43) and skin (33, 45, 46), and from human blood (30). Po- 
tent T cell stimulatory function rapidly develops when the 
dendritic ceils are cultured, most likely the result ofcytokines, 
particularly GM-CSF (45, 46) but also IL-1 (46, 55).  Since 
GM-CSF is made by made by many cell types, e.g., the ker- 
atinocytes of the skin (45),  it is possible that whenever one 
dissociates a tissue,  sufficient GM-CSF is released to trigger 
the maturation of dendritic cells that are subsequently placed 
in culture. 
Recent work (44) has described the regulated expression 
of B7-2,  a newly recognized costimulator of IL-2 produc- 
tion (see Introductory section). B7-2 expression is induced 
on B cells by LPS or by anti-Ig, and on macrophages by LPS 
or by IFN-% Here we have focused on dendritic cells. B7-2 
is difficult to detect on freshly isolated dendritic cells but when 
placed in culture, B7-2 increases  dramatically, much more 
than on any other leukocyte (Figs.  1-3). The levels of B7-2 
appear to be as high or even higher than most other known 
surface components of the dendritic cell including the HSA, 
pgp/CD44, leukocyte common antigen/CD45, LFA-3 ana- 
logue/CD48, ICAM-1/CD54, and even MHC class II (Fig. 3). 
The factors that regulate B7-2 on dendritic cells remain 
to be identified. We have achieved only partial decreases in 
B7-2 by applying anti-GM-CSF antibodies to skin cultures 
but  as mentioned, the requisite cytokines may have been 
released during the preparation of the skin cells. LSP how- 
ever, does not seem to upregulate B7-2 expression as occurs 
with macrophages and B cells (Table  1, and 44).  Likewise, 
dendritic cells upregulate B7-2 to a much greater extent than 
other APCs, when cells are placed in culture. Therefore, the 
control of B7-2 expression in dendritic cells seems to differ 
from the controls in other APCs. 
B7-1 expression, as assessed by 1G10 rat and HMB7 ham- 
ster mAbs, also is upregulated on spleen and skin dendritic 
cells in culture, but the levels of staining are much lower than 
with antibody to B7-2  (Figs.  3 and 4).  B7-2 accounts for 
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(Fig.  4, right). The block of dendritic cell function by GL-1 
anti-B7-2 was not as great as with CTLA-4 Ig, and the block 
was increased by adding the 1G10 anti-B7-1 reagent (Fig. 8). 
Whereas B7-1 may contribute less than B7-2 to the function 
of dendritic cells in the assays we studied, there may be other 
functions for B7-1 including distinct  effects  at  the level of 
the dendritic  cell rather  than  the T  cell. 
Whereas leukocytes isolated by standard methods lack B7-2, 
the molecule was readily visualized in tissue sections of lym- 
phoid organs. Again, B7-2 was easily detected, but B7-1 was 
not, using two anti-B7-1 mAbs. Most of the B7-2 + cells in 
situ appear to be macrophages and T cell area dendritic cells. 
We presume  that  these B7-2 §  cells  are difficult to release 
into suspension. Prior evidence exists that the dendritic cells 
one releases from spleen by current methods are not identical 
to the cells that occupy the central periarterial sheaths. Most 
of the  dendritic  cells  that  are  released from  spleen lack  a 
granular antigen recognized by mAb M342, but this antigen 
is upregulated with a day in culture (50).  In situ, the M342 
antigen is found within dendritic cells in the periarterial  T 
cell areas of spleen, the deep cortex of the lymph node, and 
the thymic medulla (50). This suggests that isolated splenic 
dendritic  cells  are  not  identical  to  the  M342 +  "inter- 
digitating cells" in the periarterial T areas (but may give rise 
to them).  Instead, freshly isolated dendritic cells likely cor- 
respond to intensely N418 + (CDllc + [41]) profiles within 
the marginal  zone,  at points where the periarterial  sheaths 
ofT cells enter the white pulp (41, 42). These regions repre- 
sent "doors" where T cells access the central white pulp. Like- 
wise, there is very little B7-2 reactivity in stratified squamous 
epithelia,  the location  of LC (Fig.  5,  bottom), and isolated 
epidermal dendritic cells have little B7-2 (Figs. 2 and 3). There- 
fore, the dendritic cells which one isolates from spleen and 
skin express little B7-2 in situ but upregulate the costimu- 
lator during  culture. 
We were concerned that  the B7-2  antigen in tissue sec- 
tions might represent an intracellular  biosynthetic pool. How- 
ever, B7-2 was accessible to GL-1 mAb given intravenously. 
Beginning with the studies of Linsley et al.  (2), a good 
deal of evidence has implicated  CD28/CTLA-4  ligands in 
the control of IL-2 production. Hathcock et al. (44) recently 
showed that GL-1 anti-B7-2 did not block induction of the 
IL-2 receptor in stimulated T cells, but greatly reduced IL-2 
synthesis.  For dendritic cells, the block of dendritic cell func- 
tion by anti-B7-2 reagents is incomplete (Fig. 8). It has been 
consistently observed that mAbs to a single accessory mole- 
cule on dendritic cells fail to exert a total block of APC func- 
tion (29). Part of the difficulty may relate to the high levels 
of expression of these ligands  on dendritic cells,  but most 
likely, each of the accessory molecules are playing significant 
roles in initiating  IL-2 production and DNA synthesis in T 
cells. 
Whereas the potency and other properties of different APCs 
(B cells, macrophages, and dendritic ceils) are distinct, qualita- 
tive  differences  in  the  expression  of many  adhesion  and 
costimulator molecules have yet to be encountered.  For ex- 
ample, CDlla,  CD44, CD54, CD48/58,  CD80, and B7-2 
all can be expressed on each of these APCs. What does ap- 
pear to differ are the relative levels of the accessory molecules 
and the regulation of this expression. The mean fluorescence 
intensity of the B7-2 stain on cultured splenic dendritic cells 
is much higher than that on B cells, including B cells stimu- 
lated 24 h with LPS or anti-IgM,  or on peritoneal macro- 
phages, including macrophages stimulated with LPS or IFN-',/ 
(e.g.,  Table 1,  Fig.  1).  As mentioned,  the upregulation  of 
B7-2 on cultured epidermal dendritic cells takes place within 
16 h in culture,  is long lasting  (at least 3 d in our studies; 
Figs.  2  and  3);  and  occurs  without  any additions  to  the 
medium. LPS does not seem responsible, since upregulation 
takes place equally well in LPS-unresponsive and -responsive, 
C3H/HeJ and C3H/HeN strains. Therefore, many accessory 
molecules do not vary qualitatively amongst different APCs, 
but there are differences relating  to content  and cues.  The 
dendritic cell is posed to upregulate many accessory mole- 
cules, and to high levels and for prolonged periods, upon min- 
imal provocation. 
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